La imagen puede variar dependiendo del país en el que se comercialice.
Laboratorio fabricante
Laboratorios Ovejero, S.A.
Medicamento sujeto a prescripción veterinaria
NEO-VAKY ECL
Vaccine against E. coli and Clostridium perfringens type C, in an injectable emulsion
Composición
Each 2 ml dose contains:
Active substances:
Inactivated Escherichia coli
Adjuvants:
Active substances:
Inactivated Escherichia coli
strain Bov 14 ≥ 0.826 ELISA U.*
Inactivated Escherichia coli strain Suis 29 ≥ 0.736 ELISA U.*
Inactivated Escherichia coli strain Suis 21 21 (LT enterotoxoid): 5–8 AU**
Clostridium perfringens type C ß toxoid, strain ATCC 3628 ≥ 10 IU***
Clostridium perfringens type C α toxoid, strain ATCC 3628 ≥ 5 IU***
*ELISA units in vaccinated and revaccinated rabbits with 1 ml.
**Agglutination units (LT toxoid): Inverse of the log dilution. Average agglutination units obtained in rabbits after vaccination with 1 ml.
***Unidades internacionales de antitoxina α y ß de Clostridium perfringens/ml de suero de conejos vacunados y revacunados con 1 ml de vacuna.
Adjuvants:
Mineral oil (Marcol 52) 1,260 ml
Sorbitan monooleate (Arlacel 80) 0,140 ml
Indicaciones
For passive immunisation of piglets through the active immunisation of adult and young sows (nulliparous), to reduce mortality and clinical symptoms of infections by E. coli strains expressing F4, F5, F6 and F41 adhesins and by Clostridium perfringens type C in piglets after colostrum ingestion within 6 hours of birth.
Vía de administración
Intramuscular.
Posología
Dose: 2ml
Pauta de vacunación
- Primary vaccination
- 1 dose. 3–4 weeks before parturition.
- 1 dose. 15–17 days after the first.
- Revaccination
- 1 dose. 2–3 weeks before parturition.
- In subsequent pregnancies.
Tiempo de espera
Zero days.
